Report overview
The global Rheumatology Arthritis Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Topical Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Rheumatology Arthritis Therapeutics include AbbVie, Boehringer Ingelheim GmbH, Novartis AG, Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., UCB S.A. and Johnson & Johnson Services, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Rheumatology Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatology Arthritis Therapeutics. This report contains market size and forecasts of Rheumatology Arthritis Therapeutics in global, including the following market information:
Global Rheumatology Arthritis Therapeutics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Rheumatology Arthritis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatology Arthritis Therapeutics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Rheumatology Arthritis Therapeutics Market Segment Percentages, by Type, 2023 (%)
Topical
Oral
Parenteral
Global Rheumatology Arthritis Therapeutics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Rheumatology Arthritis Therapeutics Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics
Others
Global Rheumatology Arthritis Therapeutics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Rheumatology Arthritis Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatology Arthritis Therapeutics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Rheumatology Arthritis Therapeutics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Boehringer Ingelheim GmbH
Novartis AG
Regeneron Pharmaceuticals, Inc.
Pfizer, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
UCB S.A.
Johnson & Johnson Services, Inc.
Amgen, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rheumatology Arthritis Therapeutics, market overview.
Chapter 2: Global Rheumatology Arthritis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Rheumatology Arthritis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rheumatology Arthritis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
